Calliditas Therapeutics
CALT
#5406
Rank
NZ$1.87 B
Marketcap
$68.26
Share price
-0.10%
Change (1 day)
121.85%
Change (1 year)

P/S ratio for Calliditas Therapeutics (CALT)

P/S ratio as of November 2024 (TTM): 7.19

According to Calliditas Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 109. At the end of 2024 the company had a P/S ratio of 6.92.

P/S ratio history for Calliditas Therapeutics from 2020 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20246.922.7%
20236.7413.49%
20225.93-76.2%
202124.9-99.71%
2020> 1000